Letter

Guidance on osteoporosis

Confusion from analyses and conflicts of interest

BMJ 2008; 337 doi: 10.1136/bmj.a2683 (Published 25 November 2008)
Cite this as: BMJ 2008;337:a2683

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. J Lennert Veerman, research fellow1,
  2. Theo Vos, professor1
  1. 1University of Queensland, School of Population Health, Herston, QLD 4006, Australia
  1. l.veerman{at}uq.edu.au

    The National Institute for Health and Clinical Excellence (NICE) is under heavy criticism for its osteoporosis guidelines.1 The National Osteoporosis Society argues that many people who would benefit from treatment are not treated and left with unnecessarily and unethically high fracture risks.

    The debate is, however, confused by the combination of two factors: the …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular